Kintara Therapeutics Inc (NASDAQ:KTRA) concluded the trading at $0.12 on Thursday, April 11, with a fall of -3.35% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.13 and 5Y monthly beta was reading 0.59. Considering stock’s 52-week price range provides that KTRA hit a high price of $5.98 and saw its price falling to a low level of $0.08 during that period. Over a period of past 1-month, stock came adding 48.33% in its value.
With its current market valuation of $6.86 million, Kintara Therapeutics Inc is set to declare its quarterly results on May 09, 2024 – May 13, 2024. Analysts are in estimates of $0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.46 for 2024 with estimates of that growing to -$0.38 in next year. These estimates are suggesting current year growth of 95.00% for EPS and 17.40% growth next year.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review KTRA stock’s current outlook then short term indicators are assigning it an average of Hold, while medium term indicators are categorizing the stock at an average of 50% Sell. Long term indicators are suggesting an average of 100% Sell for it.
Digging deeper we become aware of the PEG ratio of the KTRA stock which is currently positioned at 0. It further provides that stock’s current price level is 14.10% away from its 20-day simple moving average and is 15.17% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 53.95 while volatility remained at 13.39% over the past week which changes to 14.51% when measuring it over the past month. Beta is valued at 0.54, while measure of average true range or ATR is currently at 0.02.
Having a second look at Kintara Therapeutics Inc (NASDAQ:KTRA) provides that stock’s average daily trading volume for 3 months was 14.83 million, while it jumped to 31.76 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 55.30 million.
The percentage of outstanding shares held by the insiders is 0.19% while it is 0.44% for the institutional holders. The figures also indicate that as of Mar 15, 2024, number of stock’s short shares was 2.2 million which implies a short ratio of 0.11. This shows up a 5.63% of Short Interest in company’s outstanding shares on the day. In March the standing of shares short improved as it was 0.41 million in the previous month. Subtraction of -26.89% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
